
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Evidence-based clinical decision support templates for neurological diagnoses">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/plans/epidural-abscess/">
      
      
        <link rel="prev" href="../cauda-equina-syndrome/">
      
      
        <link rel="next" href="../brain-metastases/">
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>Epidural Abscess - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#spinal-epidural-abscess" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Epidural Abscess
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--active md-nav__item--section md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3" checked>
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_5" >
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../hsv-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
    
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3_6" checked>
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
      
        

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment-protocols" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT PROTOCOLS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendices" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDICES
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Headache
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Headache
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../migraine/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Migraine
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_11" >
        
          
          <label class="md-nav__link" for="__nav_3_11" id="__nav_3_11_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Movement Disorders
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_11_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_11">
            <span class="md-nav__icon md-icon"></span>
            
  
    Movement Disorders
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../parkinsons-disease-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Parkinson's Disease - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../essential-tremor/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Essential Tremor
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_12" >
        
          
          <label class="md-nav__link" for="__nav_3_12" id="__nav_3_12_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Dementia & Cognitive
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_12_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_12">
            <span class="md-nav__icon md-icon"></span>
            
  
    Dementia & Cognitive
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../dementia-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Dementia Evaluation
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_13" >
        
          
          <label class="md-nav__link" for="__nav_3_13" id="__nav_3_13_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Cranial Neuropathies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_13_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_13">
            <span class="md-nav__icon md-icon"></span>
            
  
    Cranial Neuropathies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../bells-palsy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bell's Palsy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_14" >
        
          
          <label class="md-nav__link" for="__nav_3_14" id="__nav_3_14_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_14_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_14">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment-protocols" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT PROTOCOLS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendices" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDICES
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  


  
  


<h1 id="spinal-epidural-abscess">Spinal Epidural Abscess<a class="headerlink" href="#spinal-epidural-abscess" title="Permanent link">&para;</a></h1>
<p><strong>VERSION:</strong> 1.0
<strong>CREATED:</strong> January 27, 2026
<strong>STATUS:</strong> Initial build</p>
<hr />
<p><strong>DIAGNOSIS:</strong> Spinal Epidural Abscess (SEA)</p>
<p><strong>ICD-10:</strong> G06.1 (Intraspinal abscess and granuloma), M46.40 (Discitis, unspecified site), M46.46 (Discitis, lumbar region), M46.47 (Discitis, lumbosacral region), A41.9 (Sepsis, unspecified organism)</p>
<p><strong>SYNONYMS:</strong> Spinal epidural abscess, SEA, epidural abscess, spinal abscess, vertebral osteomyelitis, discitis, spondylodiscitis, spinal infection, back pain with fever, paraspinal abscess</p>
<p><strong>SCOPE:</strong> Emergency evaluation and management of spinal epidural abscess in adults. Covers the classic triad (back pain, fever, neurologic deficit), emergent MRI, surgical drainage vs. medical management decision-making, empiric and targeted antibiotic therapy, and neurologic monitoring. Includes associated vertebral osteomyelitis and discitis. Excludes brain abscess (separate template), subdural empyema, and post-operative wound infections (partially overlaps).</p>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<p>═══════════════════════════════════════════════════════════════
SECTION A: ACTION ITEMS
═══════════════════════════════════════════════════════════════</p>
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs">1A. Essential/Core Labs<a class="headerlink" href="#1a-essentialcore-labs" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Rationale</th>
<th>Target Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>Blood cultures (x2 sets, before antibiotics)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td><strong>CRITICAL: Positive in 60-70%</strong>; identifies organism for targeted therapy; guides antibiotic duration; S. aureus most common (60-70%); draw from 2 separate sites</td>
<td>Positive → organism identification; S. aureus (MRSA vs. MSSA) most common; also Streptococci, gram-negatives, anaerobes</td>
</tr>
<tr>
<td>CBC with differential</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Leukocytosis (WBC &gt;12,000 in 60-80%); left shift; bandemia; baseline for monitoring; thrombocytopenia may indicate DIC/sepsis</td>
<td>Leukocytosis (66%); normal WBC does NOT exclude SEA (20-40% have normal WBC); leukopenia concerning for overwhelming sepsis</td>
</tr>
<tr>
<td>CMP (BMP + LFTs)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Renal function (antibiotic dosing, contrast); electrolytes; hepatic function; glucose (diabetes is major risk factor)</td>
<td>Normal or abnormal; elevated glucose → diabetes workup; renal dysfunction affects antibiotic choice</td>
</tr>
<tr>
<td>ESR (erythrocyte sedimentation rate)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td><strong>Highly sensitive (&gt;94%)</strong>; ESR &gt;20 mm/hr in nearly all cases of SEA; ESR &gt;30-50 typical; useful for monitoring treatment response</td>
<td>ESR &gt;20 mm/hr (sensitivity 94%); mean ESR is typically 50-80 mm/hr; if normal → SEA very unlikely</td>
</tr>
<tr>
<td>CRP (C-reactive protein)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Elevated in &gt;90% of SEA; more responsive to treatment changes than ESR; useful for monitoring</td>
<td>Elevated (typically &gt;10 mg/dL); declines faster than ESR with successful treatment</td>
</tr>
<tr>
<td>Procalcitonin</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>More specific for bacterial infection than CRP; helps distinguish bacterial from non-infectious inflammation; prognostic</td>
<td>&gt;0.5 ng/mL suggests bacterial infection; &gt;2.0 ng/mL concerning for sepsis; useful in atypical presentations</td>
</tr>
<tr>
<td>Blood glucose / HbA1c</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td><strong>Diabetes is a major risk factor (30-50% of SEA patients)</strong>; undiagnosed diabetes common; affects wound healing and immune function</td>
<td>Document diabetes status; HbA1c &gt;6.5% = diabetes; glucose control target &lt;180 mg/dL</td>
</tr>
<tr>
<td>PT/INR, aPTT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Coagulopathy from sepsis (DIC); surgical candidacy; baseline before anticoagulation decisions; epidural hematoma differential</td>
<td>Normal; prolonged → concern for DIC, liver dysfunction; affects surgical risk</td>
</tr>
<tr>
<td>Lactate</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Sepsis assessment; tissue hypoperfusion; prognostic</td>
<td>&lt;2 mmol/L (normal); &gt;4 mmol/L = severe sepsis/septic shock requiring aggressive resuscitation</td>
</tr>
<tr>
<td>Type and screen</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Surgical candidacy; blood product availability</td>
<td>On file</td>
</tr>
<tr>
<td>Urinalysis + urine culture</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Urinary source (UTI is common source of hematogenous spread, especially gram-negative SEA); concurrent UTI</td>
<td>Normal or pyuria/bacteriuria; if positive → potential primary source</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Rationale</th>
<th>Target Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>HIV antibody/antigen</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td>Immunocompromised state; increases SEA risk; affects prognosis and opportunistic infection risk</td>
<td>Negative; if positive → CD4 count, viral load; consider opportunistic organisms</td>
</tr>
<tr>
<td>Hepatitis B/C serologies</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>IVDU population (risk factor for SEA); affects long-term antibiotic choice; liver function</td>
<td>Negative; if positive → affects drug selection, hepatotoxicity monitoring</td>
</tr>
<tr>
<td>Hemoglobin A1c</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Undiagnosed or poorly controlled diabetes</td>
<td>&lt;6.5% (normal); ≥6.5% = diabetes; 5.7-6.4% = prediabetes</td>
</tr>
<tr>
<td>D-dimer</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>DIC screening; VTE risk (prolonged immobility + inflammation); not specific but elevated in SEA</td>
<td>Elevated (non-specific); very high levels → consider DIC</td>
</tr>
<tr>
<td>Fibrinogen</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>DIC assessment; sepsis-associated coagulopathy</td>
<td>&gt;150 mg/dL; low fibrinogen = DIC or consumption</td>
</tr>
<tr>
<td>Albumin / prealbumin</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Nutritional status; wound healing; chronicity of illness; prognostic</td>
<td>&gt;3.5 g/dL (albumin); low = poor nutrition, chronic illness</td>
</tr>
<tr>
<td>Repeat blood cultures (during treatment)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Document clearance of bacteremia; if persistently positive → evaluate for endocarditis, undrained collection, treatment failure</td>
<td>Negative by 48-72h of appropriate antibiotics; persistent positivity → echocardiogram, repeat imaging</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-refractory-or-atypical">1C. Rare/Specialized (Refractory or Atypical)<a class="headerlink" href="#1c-rarespecialized-refractory-or-atypical" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Rationale</th>
<th>Target Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>Surgical specimen culture (intraoperative)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td><strong>Gold standard for organism identification</strong>; culture of abscess material at surgery; sensitivity higher than blood cultures; also send for Gram stain and histopathology</td>
<td>Organism identification; guides targeted antibiotic therapy</td>
</tr>
<tr>
<td>CT-guided aspiration/biopsy culture</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td>If non-operative management chosen; tissue diagnosis; culture for organism identification; distinguishes abscess from tumor/hematoma</td>
<td>Organism identification; Gram stain; histopathology (rule out tumor)</td>
</tr>
<tr>
<td>Acid-fast bacilli (AFB) smear and culture</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>TB spine (Pott's disease); endemic areas; immunocompromised; chronic presentation with vertebral destruction</td>
<td>Negative; positive → TB requires different treatment (anti-TB regimen; may not need surgery if no instability/neurologic deficit)</td>
</tr>
<tr>
<td>Fungal cultures</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Immunocompromised; IVDU; indwelling catheters; endemic fungi (coccidioidomycosis, blastomycosis, histoplasmosis); chronic presentation</td>
<td>Negative; positive → prolonged antifungal therapy (6-12+ months)</td>
</tr>
<tr>
<td>Brucella serology / cultures</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Endemic areas (Mediterranean, Middle East); unpasteurized dairy; occupational exposure (farmers, veterinarians); chronic back pain</td>
<td>Negative; positive → doxycycline + streptomycin/gentamicin or rifampin</td>
</tr>
<tr>
<td>16S rRNA PCR (on tissue)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Culture-negative SEA; prior antibiotic exposure; fastidious organisms</td>
<td>Identifies organism even when cultures are negative; research/reference lab</td>
</tr>
<tr>
<td>Transthoracic echocardiogram (TTE)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td><strong>Infective endocarditis screen</strong>; IE present in 10-15% of SEA patients with S. aureus bacteremia; affects antibiotic duration and management</td>
<td>Normal; vegetations → endocarditis diagnosis; changes antibiotic duration to 4-6 weeks minimum</td>
</tr>
<tr>
<td>Transesophageal echocardiogram (TEE)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>If TTE negative but high suspicion for endocarditis (S. aureus bacteremia, IVDU, prosthetic valve, persistent fever); TEE more sensitive than TTE</td>
<td>Normal; vegetations → endocarditis; TEE sensitivity 90-95% vs. TTE 65%</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI entire spine with and without contrast (gadolinium)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">STAT</td>
<td><strong>GOLD STANDARD — within 4 hours of ED presentation if neurologic deficit; within 24h if no deficit</strong>; contrast essential for abscess characterization; image ENTIRE spine (multifocal in 15-20%)</td>
<td>Epidural collection with ring enhancement; T1 hypointense, T2 hyperintense; restricted diffusion (DWI bright, ADC dark within abscess); vertebral body involvement (osteomyelitis); disc involvement (discitis); cord compression; degree of canal compromise</td>
<td>MRI-incompatible implants; severe claustrophobia (sedate — do NOT delay); GFR &lt;30 (gadolinium risk — but benefit outweighs risk in emergency)</td>
</tr>
<tr>
<td>Plain radiographs (spine)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Immediate while awaiting MRI; identifies vertebral body destruction, disc space narrowing, alignment abnormality; LOW sensitivity for early SEA</td>
<td>Disc space narrowing; vertebral body destruction (late finding — takes 2-4 weeks to appear); alignment; pathologic fracture</td>
<td>Pregnancy (shield)</td>
</tr>
<tr>
<td>CT spine without contrast</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>If MRI unavailable or contraindicated; inferior to MRI for soft tissue and epidural collection; shows bone destruction better than MRI</td>
<td>Bone destruction; disc space narrowing; paraspinal soft tissue mass; canal compromise; less sensitive than MRI for epidural abscess extent</td>
<td>Pregnancy (relative)</td>
</tr>
<tr>
<td>Chest X-ray</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Primary pulmonary source (pneumonia); lung abscess; TB (apical infiltrate, cavitation); septic emboli</td>
<td>Primary infection source; pulmonary complications; TB features</td>
<td>Pregnancy (shield)</td>
</tr>
</tbody>
</table>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
</tr>
</thead>
<tbody>
<tr>
<td>CT chest/abdomen/pelvis with contrast</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>Source identification if not obvious; look for primary infection (lung abscess, intra-abdominal abscess, psoas abscess); staging for concurrent infection</td>
<td>Primary source: lung abscess, intra-abdominal abscess, psoas abscess (contiguous spread), renal/perinephric abscess; endocarditis emboli</td>
<td>Contrast allergy; renal impairment</td>
</tr>
<tr>
<td>Echocardiogram (TTE → TEE if needed)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td><strong>All patients with S. aureus bacteremia should have echocardiogram</strong>; endocarditis in 10-15% of S. aureus SEA</td>
<td>Vegetations; valvular regurgitation; abscess; Duke criteria</td>
<td>None (TTE); TEE: esophageal pathology, uncooperative patient</td>
</tr>
<tr>
<td>CT myelogram</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td>Only if MRI absolutely contraindicated; intrathecal contrast via LP followed by CT; demonstrates level of compression; risk of meningitis seeding with LP</td>
<td>Complete or partial block; level of compression; intradural vs. extradural</td>
<td>Infection at LP site (SEA itself may preclude LP at involved level); coagulopathy</td>
</tr>
<tr>
<td>Nuclear medicine bone scan (Tc-99m)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>If MRI unavailable; can identify osteomyelitis; may show uptake before radiographic changes; less specific than MRI</td>
<td>Increased uptake at infection site(s); may identify multifocal disease</td>
<td>Pregnancy; limited specificity</td>
</tr>
<tr>
<td>Gallium-67 or Indium-111 WBC scan</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Chronic/subacute infection; differentiating active infection from degenerative changes; research use</td>
<td>Increased uptake at infection site</td>
<td>Limited availability; time-consuming; replaced largely by MRI</td>
</tr>
</tbody>
</table>
<h3 id="2c-rareadvanced">2C. Rare/Advanced<a class="headerlink" href="#2c-rareadvanced" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
</tr>
</thead>
<tbody>
<tr>
<td>CT-guided biopsy/aspiration</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td>If diagnosis uncertain; culture acquisition for non-surgical management; distinguish abscess from tumor or hematoma</td>
<td>Organism identification; Gram stain; histopathology confirming infection vs. other pathology</td>
<td>Coagulopathy; inaccessible location; very small collection</td>
</tr>
<tr>
<td>PET/CT (FDG)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Chronic/recurrent infection; assess treatment response; identify additional sites of infection; research use</td>
<td>Increased FDG uptake at infection site; may identify occult primary source</td>
<td>Uncontrolled diabetes (glucose &gt;200); pregnancy</td>
</tr>
<tr>
<td>Repeat MRI (during treatment)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>At 2-4 weeks or if clinical worsening; assess treatment response; monitor for abscess expansion; may appear worse before better on imaging</td>
<td>Stable or decreasing collection size; resolving edema; NOTE: Imaging may lag behind clinical improvement (may appear worse at 2 weeks even with successful treatment)</td>
<td>Same as initial MRI</td>
</tr>
<tr>
<td>Post-treatment MRI</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>At end of antibiotic course (6-8 weeks); baseline for comparison; assess for residual disease</td>
<td>Resolution or significant improvement of collection; healed osteomyelitis; residual enhancement may persist for months (does not necessarily indicate active infection)</td>
<td>Same as MRI</td>
</tr>
</tbody>
</table>
<h3 id="lumbar-puncture">Lumbar Puncture<a class="headerlink" href="#lumbar-puncture" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
</tr>
</thead>
<tbody>
<tr>
<td>LP — Generally NOT indicated</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td><strong>LP is generally CONTRAINDICATED in suspected SEA</strong>; risk of seeding infection into subarachnoid space → meningitis/spinal subdural empyema; imaging (MRI) is diagnostic modality of choice</td>
<td>N/A</td>
<td><strong>AVOID LP if SEA suspected</strong> — LP may spread infection into intradural space; if meningitis suspected concurrently, discuss with neurosurgery/ID before LP</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="3-treatment-protocols">3. TREATMENT PROTOCOLS<a class="headerlink" href="#3-treatment-protocols" title="Permanent link">&para;</a></h2>
<h3 id="3a-acuteemergent-treatment">3A. Acute/Emergent Treatment<a class="headerlink" href="#3a-acuteemergent-treatment" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Protocol</th>
<th>Evidence/Rationale</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Empiric IV antibiotics (STAT)</strong></td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td><strong>Start IMMEDIATELY after blood cultures drawn — do NOT delay for MRI or organism identification</strong>; <strong>First-line empiric:</strong> Vancomycin 25-30 mg/kg IV load (max 2g), then 15-20 mg/kg IV q8-12h (target trough 15-20 mcg/mL) PLUS Ceftriaxone 2g IV q12h OR Cefepime 2g IV q8h; <strong>Alternative for β-lactam allergy:</strong> Vancomycin + aztreonam 2g IV q8h OR Vancomycin + fluoroquinolone (levofloxacin 750 mg daily); <strong>If Pseudomonas risk (IVDU, immunocompromised):</strong> Add anti-pseudomonal coverage with cefepime or piperacillin-tazobactam 4.5g IV q6h; <strong>Adjust to culture results when available</strong></td>
<td>Vancomycin covers MRSA (most important cause); ceftriaxone/cefepime covers MSSA, streptococci, gram-negatives; early antibiotics are associated with better outcomes; every hour of delay increases mortality in sepsis</td>
</tr>
<tr>
<td><strong>Emergent surgical decompression + drainage</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td><strong>INDICATIONS (Surgery preferred):</strong> (1) Neurologic deficit (any weakness, bowel/bladder dysfunction), (2) Sepsis/hemodynamic instability not improving with antibiotics, (3) Significant cord compression on imaging, (4) Failure of medical therapy (no improvement at 48-72h, worsening at any time), (5) Unknown organism (need tissue diagnosis); <strong>Procedure:</strong> Posterior laminectomy with abscess drainage; cultures from abscess; débridement of infected tissue; may need instrumentation if instability; <strong>Timing:</strong> Within 24h of diagnosis; emergent (within hours) if progressive deficit</td>
<td>Darouiche (2006): Surgical outcomes better than medical management in patients with neurologic deficit; earlier surgery (within 24h) associated with better neurologic recovery; pre-operative neurologic status is #1 predictor of outcome</td>
</tr>
<tr>
<td><strong>DVT prophylaxis</strong></td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>SCDs immediately; pharmacologic prophylaxis: enoxaparin 40 mg SQ daily — timing is nuanced: may start within 24h of admission if no imminent surgery; post-operatively start 12-24h after surgery per surgeon; high VTE risk population</td>
<td>Immobile + infection + inflammatory state = very high DVT risk; mechanical prophylaxis universal; pharmacologic prophylaxis as soon as surgically safe</td>
</tr>
<tr>
<td><strong>Pain management</strong></td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Back pain often severe; acetaminophen 650-1000 mg q6h (scheduled) + opioids (morphine 2-4 mg IV q3h PRN or hydromorphone 0.5-1 mg IV q3h PRN); NSAIDs: use cautiously (renal function, surgical bleeding) — some ID physicians avoid NSAIDs in active infection; neuropathic agents (gabapentin) if radicular component</td>
<td>Severe pain is hallmark of SEA; adequate analgesia is essential; balance with need for neurologic monitoring</td>
</tr>
<tr>
<td><strong>Sepsis resuscitation (if septic)</strong></td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Surviving Sepsis guidelines: lactate measurement; blood cultures before antibiotics; IV crystalloid 30 mL/kg for hypotension or lactate ≥4 mmol/L; vasopressors (norepinephrine first-line) if MAP &lt;65 despite fluids; reassess volume status; repeat lactate if initially elevated</td>
<td>Sepsis from SEA has high mortality; early aggressive resuscitation improves outcomes</td>
</tr>
<tr>
<td><strong>Glucose control</strong></td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Target glucose &lt;180 mg/dL; insulin infusion if critically ill; sliding scale or basal-bolus for non-ICU patients; diabetes is major risk factor — optimize control</td>
<td>Hyperglycemia impairs immune function and wound healing; tight glucose control improves infection outcomes</td>
</tr>
</tbody>
</table>
<h3 id="3b-definitivetargeted-treatment">3B. Definitive/Targeted Treatment<a class="headerlink" href="#3b-definitivetargeted-treatment" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Protocol</th>
<th>Evidence/Rationale</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Targeted IV antibiotic therapy (based on culture results)</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td><strong>Tailor to organism and sensitivities; typical regimens:</strong> — <strong>MSSA:</strong> Nafcillin 2g IV q4h OR cefazolin 2g IV q8h (preferred for tolerability); duration 6-8 weeks; — <strong>MRSA:</strong> Vancomycin 15-20 mg/kg IV q8-12h (trough 15-20) for 6-8 weeks; alternatives: daptomycin 6-8 mg/kg IV daily (avoid if pneumonia), linezolid 600 mg IV/PO q12h (monitor for toxicity if &gt;2 weeks); — <strong>Streptococci:</strong> Penicillin G 4 million units IV q4h or ceftriaxone 2g IV q12h x 6 weeks; — <strong>Enterococcus:</strong> Ampicillin 2g IV q4h (if susceptible) ± gentamicin synergy; vancomycin if ampicillin-resistant; — <strong>Gram-negatives:</strong> Ceftriaxone 2g IV q12h or cefepime 2g IV q8h or ciprofloxacin 400 mg IV q8h x 6 weeks depending on sensitivities; — <strong>Pseudomonas:</strong> Cefepime 2g IV q8h or meropenem 2g IV q8h x 6 weeks</td>
<td>IV antibiotics are standard for SEA/osteomyelitis; oral transition data emerging (OVIVA trial) but traditionally 6-8 weeks IV; de-escalate from empiric coverage once cultures return</td>
</tr>
<tr>
<td><strong>Duration of antibiotics</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td><strong>SEA without osteomyelitis:</strong> 4-6 weeks IV; <strong>SEA with vertebral osteomyelitis (most cases):</strong> 6-8 weeks IV; <strong>SEA with endocarditis:</strong> 6 weeks minimum from first negative blood culture; duration guided by clinical response, inflammatory markers (ESR, CRP), repeat imaging; may extend if slow response</td>
<td>IDSA guidelines: 6 weeks for vertebral osteomyelitis; 4-6 weeks for epidural abscess alone; endocarditis requires 6-week minimum; individualized based on response</td>
</tr>
<tr>
<td><strong>Oral antibiotic transition (selected cases)</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td><strong>OVIVA trial (2019):</strong> Oral antibiotics non-inferior to IV for bone/joint infections after initial 2 weeks IV in stable patients; <strong>Candidates:</strong> Clinically improving; afebrile; tolerating PO; CRP trending down; adherent; close follow-up available; <strong>Oral options:</strong> Fluoroquinolone (levofloxacin 750 mg daily or ciprofloxacin 750 mg BID) + rifampin 300 mg BID (NOT monotherapy); linezolid 600 mg BID (monitor CBC, neuropathy); TMP-SMX DS 2 tabs BID (for MRSA); <strong>NOT for:</strong> Endocarditis, undrained abscess, persistent bacteremia, non-adherent patient</td>
<td>OVIVA trial showed oral switch after 2 weeks IV is non-inferior for bone/joint infections; reduces costs, IV complications, hospital stay; requires careful patient selection and close monitoring; NOT standard for all SEA cases</td>
</tr>
<tr>
<td><strong>Surgical drainage (if not done emergently)</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td><strong>If initial medical management:</strong> Re-evaluate need for surgery at 48-72h; indications for delayed surgery: failure to improve, neurologic deterioration, persistent fever/bacteremia, abscess enlargement on imaging; <strong>Procedure:</strong> Laminectomy + drainage; send cultures even if already on antibiotics (may still grow organism); instrumented fusion if instability/destruction</td>
<td>Surgery provides source control, tissue diagnosis, and decompression; delayed surgery for medical failure still beneficial if performed before complete paralysis</td>
</tr>
<tr>
<td><strong>Medical management alone (selected cases)</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td><strong>Candidates for medical management without surgery:</strong> (1) No neurologic deficit, (2) Organism identified (blood cultures positive), (3) Small abscess (&lt;3 cm collection), (4) Poor surgical candidate (extreme comorbidities), (5) Panspinal disease (multiple levels — surgery impractical); <strong>Requirements:</strong> Very close neurologic monitoring (q2-4h initially); repeat MRI at 48-72h and weekly; immediate surgery if any deterioration; adherent patient</td>
<td>Observational studies: ~40% of SEA can be managed medically if no neurologic deficit and criteria met; HOWEVER, 10-20% will fail medical therapy and require surgery; early surgery generally preferred if feasible</td>
</tr>
</tbody>
</table>
<h3 id="3c-adjunctive-treatment">3C. Adjunctive Treatment<a class="headerlink" href="#3c-adjunctive-treatment" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Protocol</th>
<th>Evidence/Rationale</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>PICC line placement</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>If prolonged IV antibiotics planned (6-8 weeks); enables outpatient IV therapy (OPAT); placed once stabilized and duration confirmed; confirm tip position with X-ray</td>
<td>Required for OPAT; reduces peripheral IV complications; monitor for PICC-associated infection</td>
</tr>
<tr>
<td><strong>Outpatient parenteral antibiotic therapy (OPAT)</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Once clinically stable (afebrile, pain controlled, neurologically stable, adequate PO intake, safe home environment); PICC in place; infusion teaching completed; close ID follow-up (weekly visits); VNA nursing for line care</td>
<td>Reduces hospital stay; comparable outcomes to inpatient therapy in appropriate patients; weekly ID visits with labs (CBC, CMP, drug levels, CRP)</td>
</tr>
<tr>
<td><strong>Rifampin (adjunctive)</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>For staphylococcal osteomyelitis (vertebral involvement); enhances bone penetration; prevents biofilm; <strong>ONLY as adjunctive therapy — never monotherapy (rapid resistance)</strong>; Rifampin 300 mg PO BID added to primary anti-staphylococcal agent; check interactions (CYP3A4 inducer — reduces warfarin, HIV meds, oral contraceptives, etc.)</td>
<td>Rifampin improves outcomes in staphylococcal bone infections; biofilm activity; excellent bone penetration; drug interactions are significant</td>
</tr>
<tr>
<td><strong>Bracing / spinal orthosis</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>If spinal instability (vertebral body destruction, kyphosis, instrumentation); TLSO for thoracolumbar; cervical collar for cervical; duration: typically 6-12 weeks or until radiographic healing</td>
<td>External stabilization; pain relief; prevents pathologic fracture progression; may allow non-operative management of mild instability</td>
</tr>
<tr>
<td><strong>Nutritional optimization</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Protein supplementation (1.2-1.5 g/kg/day); calorie optimization; correct vitamin deficiencies; dietitian consultation; affects wound healing and immune function</td>
<td>Malnutrition common in chronic illness; protein essential for wound healing; improves infection outcomes</td>
</tr>
<tr>
<td><strong>Diabetes optimization</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Endocrinology consult if poorly controlled; insulin titration; goal HbA1c &lt;7.5% (individualized); glucose &lt;180 mg/dL during acute illness</td>
<td>Diabetes is major risk factor; uncontrolled diabetes impairs healing and immune response</td>
</tr>
<tr>
<td><strong>Substance abuse counseling (if applicable)</strong></td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>IVDU is major risk factor for SEA (20-30% of cases); addiction medicine consultation; harm reduction; hepatitis/HIV screening; reduces recurrence risk</td>
<td>IVDU patients at high risk for recurrent infection; addressing substance use reduces future SEA risk</td>
</tr>
</tbody>
</table>
<h3 id="3d-medications-to-avoid-or-use-with-caution">3D. Medications to AVOID or Use with Caution<a class="headerlink" href="#3d-medications-to-avoid-or-use-with-caution" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Risk/Concern</th>
<th>Alternative</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daptomycin (with pneumonia)</td>
<td>Inactivated by lung surfactant; NOT effective for pneumonia; OK for SEA without pulmonary involvement</td>
<td>Vancomycin or linezolid if concurrent pulmonary infection</td>
</tr>
<tr>
<td>Rifampin monotherapy</td>
<td>Rapid development of resistance (within days); NEVER use rifampin alone; must always be combined with second anti-staphylococcal agent</td>
<td>Rifampin only as adjunct to vancomycin, nafcillin, daptomycin, etc.</td>
</tr>
<tr>
<td>Linezolid &gt;2-4 weeks</td>
<td>Myelosuppression (thrombocytopenia); peripheral and optic neuropathy (often irreversible); serotonin syndrome (with SSRIs)</td>
<td>Weekly CBC monitoring; limit duration; consider alternatives for long courses; discontinue if neuropathy develops</td>
</tr>
<tr>
<td>Aminoglycosides (prolonged use)</td>
<td>Nephrotoxicity; ototoxicity; reserve for synergy in enterococcal infections; short-term use only</td>
<td>Non-aminoglycoside regimens preferred; if used, limit to 2 weeks</td>
</tr>
<tr>
<td>Corticosteroids (routine use)</td>
<td>May impair immune response and abscess control; NOT indicated routinely in SEA (unlike MSCC where tumor-related edema is target)</td>
<td>Avoid steroids unless concurrent severe cord edema causing neurologic decline AND after ID consultation; NOT standard</td>
</tr>
<tr>
<td>NSAIDs (prolonged, peri-operative)</td>
<td>Renal toxicity (especially with vancomycin); impaired bone healing (controversial); peri-operative bleeding</td>
<td>Acetaminophen; opioids; gabapentin for neuropathic pain; minimize NSAID exposure</td>
</tr>
<tr>
<td>LP (in suspected SEA)</td>
<td>Risk of seeding infection into intradural space → meningitis, subdural empyema; LP is contraindicated if SEA suspected</td>
<td>MRI is diagnostic modality; avoid LP unless concurrent meningitis suspected and discussed with specialists</td>
</tr>
<tr>
<td>Epidural steroid injection (as treatment or in area of abscess)</td>
<td>Does NOT treat SEA; may worsen infection; epidural procedure may spread infection; if recent ESI → could be iatrogenic cause</td>
<td>Surgical drainage; IV antibiotics; ESI is a risk factor for SEA, not a treatment</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-essential">4A. Essential<a class="headerlink" href="#4a-essential" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr>
<td>Spine surgery / Neurosurgery consultation — EMERGENT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td><strong>Consult IMMEDIATELY on suspicion</strong> — before or concurrent with MRI; surgery vs. medical management decision; ALL patients with SEA need spine surgery evaluation even if medical management is planned (contingency for neurologic deterioration)</td>
</tr>
<tr>
<td>Infectious disease consultation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Antibiotic selection; duration; OPAT planning; monitoring plan; repeat imaging decisions; often co-manage with surgery</td>
</tr>
<tr>
<td>Neurologic examination — serial monitoring</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td><strong>CRITICAL:</strong> q2-4h neurologic checks initially; document motor strength (bilateral LE myotomes), sensory level, rectal tone, bladder function; ANY deterioration → STAT surgical evaluation; pre-operative neuro status is the #1 outcome predictor</td>
</tr>
<tr>
<td>Source identification</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Identify primary infection source: skin/soft tissue (cellulitis, IV site), UTI, endocarditis, dental abscess, pneumonia, intra-abdominal abscess, recent procedure (epidural injection, spinal surgery); treat primary source</td>
</tr>
<tr>
<td>Blood cultures (before antibiotics)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>CRITICAL — positive in 60-70%; draw 2 sets from separate sites; do NOT delay antibiotics if cultures cause delay — draw quickly and start treatment</td>
</tr>
<tr>
<td>Fall precautions / mobility assessment</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>SEA patients may have weakness, sensory loss, impaired balance; fall risk assessment; assistive devices; PT/OT evaluation</td>
</tr>
<tr>
<td>Documentation of timeline</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Document: time of symptom onset (back pain → radiculopathy → weakness is classic progression over days-weeks), time of presentation, time of MRI, time of surgical consultation, time of antibiotics, neurologic exam at each time point</td>
</tr>
</tbody>
</table>
<h3 id="4b-extended">4B. Extended<a class="headerlink" href="#4b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr>
<td>Echocardiogram (TTE ± TEE)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>All patients with S. aureus bacteremia (IE in 10-15%); if TTE negative but high suspicion → TEE; affects antibiotic duration and management</td>
</tr>
<tr>
<td>Dental evaluation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Dental abscess as source; poor dentition as risk factor; dental clearance before prolonged antibiotics (if teeth issues could reinfect)</td>
</tr>
<tr>
<td>PICC placement / vascular access</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Long-term IV access for 6-8 weeks of antibiotics; PICC is standard; peripherally inserted; confirm tip position</td>
</tr>
<tr>
<td>Social work / case management</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>OPAT coordination; home infusion setup; substance abuse services; insurance authorization; discharge planning</td>
</tr>
<tr>
<td>Addiction medicine (if IVDU)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>IVDU is major risk factor (20-30%); buprenorphine or methadone initiation; harm reduction; reduces future infection risk</td>
</tr>
<tr>
<td>Pain management service</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Chronic pain common after SEA; multimodal approach; avoid long-term opioids if possible; neuropathic agents</td>
</tr>
<tr>
<td>Physical / occupational therapy</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Mobility assessment; strengthening; ADL training; rehabilitation planning if neurologic deficits</td>
</tr>
<tr>
<td>VNA / home health</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>PICC care; medication assistance; wound care (if post-operative); safety checks</td>
</tr>
</tbody>
</table>
<h3 id="4c-atypicalrefractory">4C. Atypical/Refractory<a class="headerlink" href="#4c-atypicalrefractory" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr>
<td>Repeat MRI</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>At 48-72h if medically managed (assess for enlargement); at 2-4 weeks (assess treatment response — NOTE: imaging may appear worse before better); at end of treatment (baseline); PRN if clinical worsening</td>
</tr>
<tr>
<td>CT-guided drainage (percutaneous)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td>Alternative to surgery in selected cases (poor surgical candidate, small collection, posterior access); less reliable than surgical drainage; may be repeated if recurrence</td>
</tr>
<tr>
<td>Revision surgery / repeat drainage</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>If treatment failure (persistent fever, neurologic decline, enlarging collection); undrained loculations; retained infected hardware</td>
</tr>
<tr>
<td>Infectious disease second opinion</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Culture-negative SEA; unusual organism; treatment failure; complex antibiotic decisions</td>
</tr>
<tr>
<td>Long-term suppressive antibiotics</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Selected cases with retained hardware, incompletely treated osteomyelitis, immunocompromised; oral suppressive therapy (TMP-SMX, doxycycline, or other based on organism) after initial 6-8 week course; indefinite duration in some cases</td>
</tr>
<tr>
<td>Spinal fusion (delayed)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>If significant vertebral destruction and instability after infection controlled; typically 6-12 weeks after infection resolution; staged reconstruction</td>
</tr>
<tr>
<td>Hyperbaric oxygen therapy</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Refractory osteomyelitis; adjunctive to antibiotics and surgery; limited evidence but some centers use for difficult cases</td>
</tr>
</tbody>
</table>
<hr />
<p>═══════════════════════════════════════════════════════════════
SECTION B: SUPPORTING INFORMATION
═══════════════════════════════════════════════════════════════</p>
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<h3 id="primary-differential-diagnoses">Primary Differential Diagnoses<a class="headerlink" href="#primary-differential-diagnoses" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Diagnosis</th>
<th>Key Differentiating Features</th>
<th>Distinguishing Studies</th>
</tr>
</thead>
<tbody>
<tr>
<td>Malignant spinal cord compression (MSCC) / Metastatic epidural disease</td>
<td>Known cancer history; bone destruction without disc involvement (SEA typically involves disc); no fever (usually); no elevated ESR/CRP/WBC (unless concurrent infection); may be painful but not typically as acute; enhances but no ring-enhancement or diffusion restriction</td>
<td>MRI: enhancing epidural mass WITHOUT ring enhancement or restricted diffusion; bone destruction; CT/PET: metastatic staging; tumor markers; biopsy if uncertain; ESR/CRP may be mildly elevated in malignancy but not as high as SEA</td>
</tr>
<tr>
<td>Vertebral compression fracture (osteoporotic)</td>
<td>Older patient; osteoporosis history; no fever; acute onset with movement; no neurologic deficit (usually); no elevated inflammatory markers; vertebral body wedging; may have benign edema</td>
<td>MRI: vertebral body edema WITHOUT epidural collection; no ring enhancement; normal ESR/CRP; DEXA: osteoporosis; mechanism (fall, lifting); responds to bracing/pain management</td>
</tr>
<tr>
<td>Disc herniation (without infection)</td>
<td>No fever; no elevated inflammatory markers; unilateral radiculopathy (usually); no epidural collection on MRI; common, benign presentation</td>
<td>MRI: disc herniation without epidural enhancement; no T2 hyperintense collection; normal ESR/CRP; normal WBC; unilateral symptoms more common</td>
</tr>
<tr>
<td>Spinal epidural hematoma</td>
<td>Anticoagulation; post-procedural (epidural injection, LP, surgery); acute onset; hematoma signal characteristics on MRI (not ring-enhancing); no fever; rapidly progressive</td>
<td>MRI: epidural collection with blood signal (T1 hyperintense in subacute phase); NO ring enhancement; NO restricted diffusion in hematoma (unlike abscess); coagulation studies; anticoagulation history; recent procedure</td>
</tr>
<tr>
<td>Transverse myelitis / NMOSD</td>
<td>Intramedullary (within cord) rather than epidural; autoimmune; no fever; no elevated ESR/CRP (or mildly elevated); subacute onset; responds to steroids/PLEX</td>
<td>MRI: intramedullary T2 hyperintensity, NOT epidural collection; AQP4/MOG antibodies; CSF: pleocytosis but sterile; normal inflammatory markers</td>
</tr>
<tr>
<td>Degenerative lumbar stenosis</td>
<td>Chronic symptoms (claudication); older patient; no fever; no inflammatory markers; bilateral symptoms with walking; relieved by sitting/flexion; chronic findings on MRI</td>
<td>MRI: chronic stenosis (ligamentum flavum hypertrophy, disc bulging, facet hypertrophy) WITHOUT acute epidural collection; normal ESR/CRP; chronic history</td>
</tr>
<tr>
<td>Vertebral osteomyelitis (without epidural extension)</td>
<td>Similar to SEA but NO epidural collection; disc and vertebral body involvement; back pain and fever; elevated inflammatory markers; may progress to SEA</td>
<td>MRI: vertebral body and disc enhancement and edema WITHOUT epidural collection; blood cultures may be positive; requires IV antibiotics but not emergent surgical decompression (unless instability or progression to SEA)</td>
</tr>
<tr>
<td>Psoas abscess</td>
<td>Contiguous spread can cause spinal infection; flank/groin pain; hip flexion pain; may track from spine or vice versa; fever; iliopsoas enhancement on imaging</td>
<td>CT/MRI: psoas muscle enlargement with rim-enhancing collection; may extend to spine; blood cultures; percutaneous drainage often possible</td>
</tr>
</tbody>
</table>
<h3 id="classic-clinical-triad-only-present-in-10-15">Classic Clinical Triad (Only present in 10-15%)<a class="headerlink" href="#classic-clinical-triad-only-present-in-10-15" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Phase</th>
<th>Symptom</th>
<th>Timing</th>
</tr>
</thead>
<tbody>
<tr>
<td>Phase 1</td>
<td>Back pain (localized, severe)</td>
<td>Days to weeks before diagnosis</td>
</tr>
<tr>
<td>Phase 2</td>
<td>Radicular pain (nerve root irritation)</td>
<td>Days after back pain onset</td>
</tr>
<tr>
<td>Phase 3</td>
<td>Neurologic deficit (weakness, bowel/bladder)</td>
<td>Hours to days after radicular pain</td>
</tr>
</tbody>
</table>
<p><strong>NOTE:</strong> The classic triad (back pain → radiculopathy → paralysis) is present in only 10-15% of patients at presentation. Most patients present with 1-2 features. Maintain HIGH suspicion in any patient with back pain + fever, especially with risk factors.</p>
<h3 id="red-flags-requiring-urgent-reassessment">Red Flags Requiring Urgent Reassessment<a class="headerlink" href="#red-flags-requiring-urgent-reassessment" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Red Flag</th>
<th>Concern</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANY new neurologic deficit (weakness, sensory loss, bladder dysfunction)</td>
<td>Progression of cord/root compression; medical management failure</td>
<td>STAT MRI; immediate surgical consultation; emergent decompression if progressive</td>
</tr>
<tr>
<td>Fever not improving after 48-72h of antibiotics</td>
<td>Undrained collection; wrong antibiotic coverage; drug fever; secondary site</td>
<td>Repeat imaging (MRI); reassess antibiotic coverage; consider surgical drainage</td>
</tr>
<tr>
<td>Persistent or worsening back pain</td>
<td>Abscess enlargement; vertebral instability; pathologic fracture</td>
<td>Repeat MRI; surgical re-evaluation; bracing assessment</td>
</tr>
<tr>
<td>Persistent bacteremia</td>
<td>Undrained source; endocarditis; seeded secondary site</td>
<td>TEE; repeat imaging; consider surgery for source control</td>
</tr>
<tr>
<td>Sepsis not resolving</td>
<td>Inadequate source control; resistant organism; secondary infection</td>
<td>ICU reassessment; surgical drainage if not done; broaden antibiotics; repeat cultures</td>
</tr>
<tr>
<td>New back pain at different level</td>
<td>Multifocal SEA (present in 15-20%); skip lesion</td>
<td>MRI whole spine (if not already done); assess new level</td>
</tr>
<tr>
<td>Rising inflammatory markers after initial improvement</td>
<td>Treatment failure; secondary infection; abscess loculation</td>
<td>Repeat imaging; reassess antibiotic coverage; surgical consultation</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<h3 id="acute-phase-monitoring-first-72h">Acute Phase Monitoring (First 72h)<a class="headerlink" href="#acute-phase-monitoring-first-72h" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target</th>
<th>Action if Abnormal</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurologic examination (motor strength, sensory level, rectal tone, bladder)</td>
<td>q2-4h initially; q4-6h once stable</td>
<td>Stable or improving; NO new deficits</td>
<td>ANY deterioration → STAT MRI → emergent surgical consultation → likely emergent decompression</td>
</tr>
<tr>
<td>Temperature</td>
<td>q4h</td>
<td>Afebrile (&lt;38°C) by 48-72h of antibiotics</td>
<td>Persistent fever: repeat cultures; imaging for undrained collection; reassess antibiotics; echocardiogram</td>
</tr>
<tr>
<td>Blood pressure / hemodynamics</td>
<td>Continuous if septic; q4h if stable</td>
<td>MAP &gt;65; resolving sepsis</td>
<td>Vasopressors; fluid resuscitation; ICU care for septic shock</td>
</tr>
<tr>
<td>Pain score (NRS)</td>
<td>q4h</td>
<td>Improving; NRS &lt;4/10</td>
<td>Escalate analgesia; worsening pain may indicate abscess enlargement or instability</td>
</tr>
<tr>
<td>Blood cultures (repeat)</td>
<td>Daily until negative</td>
<td>Negative cultures within 48-72h of appropriate antibiotics</td>
<td>Persistent bacteremia: echocardiogram (TEE); imaging for undrained focus; consider surgery</td>
</tr>
<tr>
<td>WBC, CRP</td>
<td>Daily initially</td>
<td>Trending down</td>
<td>Rising inflammatory markers: treatment failure; repeat imaging; reassess management</td>
</tr>
<tr>
<td>Vancomycin trough (if on vancomycin)</td>
<td>Before 4th dose; then 2-3x/week</td>
<td>15-20 mcg/mL (for serious infection)</td>
<td>Adjust dose if outside range; monitor renal function</td>
</tr>
<tr>
<td>Renal function (BUN/Cr)</td>
<td>Daily initially; 2-3x/week ongoing</td>
<td>Stable</td>
<td>Nephrotoxicity: adjust vancomycin and other renally-cleared drugs; adequate hydration</td>
</tr>
<tr>
<td>Blood glucose</td>
<td>q6h (q4h if critically ill)</td>
<td>&lt;180 mg/dL</td>
<td>Insulin titration</td>
</tr>
</tbody>
</table>
<h3 id="subacute-monitoring-hospital-and-opat">Subacute Monitoring (Hospital and OPAT)<a class="headerlink" href="#subacute-monitoring-hospital-and-opat" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target</th>
<th>Action if Abnormal</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurologic examination</td>
<td>Daily (hospital); weekly (OPAT)</td>
<td>Stable or improving</td>
<td>New deficits: urgent MRI; surgical re-evaluation</td>
</tr>
<tr>
<td>ESR</td>
<td>Weekly</td>
<td>Declining trend (may take 3-4 weeks to start declining); normalize by 6-8 weeks (varies)</td>
<td>Not declining: consider treatment failure; repeat imaging; ID reassessment</td>
</tr>
<tr>
<td>CRP</td>
<td>Weekly</td>
<td>Should decline within 1-2 weeks; normalize before ESR</td>
<td>Rising CRP: treatment failure; repeat imaging</td>
</tr>
<tr>
<td>CBC (especially if on linezolid)</td>
<td>Weekly</td>
<td>Stable; no cytopenias</td>
<td>Linezolid: thrombocytopenia, anemia → consider discontinuation if &lt;2 weeks remaining or switch agent</td>
</tr>
<tr>
<td>Renal function + vancomycin trough</td>
<td>2-3x/week; weekly once stable</td>
<td>Stable; trough 15-20</td>
<td>Dose adjustment</td>
</tr>
<tr>
<td>LFTs (if on rifampin)</td>
<td>Weekly</td>
<td>Stable</td>
<td>Transaminases &gt;3x ULN: consider discontinuing rifampin</td>
</tr>
<tr>
<td>PICC line site</td>
<td>Daily</td>
<td>No erythema, drainage, tenderness</td>
<td>Line infection: remove PICC; cultures; may need new site</td>
</tr>
<tr>
<td>MRI spine</td>
<td>At 2-4 weeks; end of treatment; PRN for symptoms</td>
<td>Improving or stable; abscess resolving; NOTE: imaging may lag behind clinical improvement</td>
<td>Enlarging abscess despite antibiotics: surgical drainage; worsening imaging despite clinical improvement may be normal at 2-4 weeks</td>
</tr>
</tbody>
</table>
<h3 id="long-term-follow-up">Long-term Follow-up<a class="headerlink" href="#long-term-follow-up" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target</th>
<th>Action if Abnormal</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clinic visit (ID)</td>
<td>Weekly during OPAT; 2 weeks after completion; 3 months; 6 months; 12 months</td>
<td>No relapse; no recurrence</td>
<td>Relapse: repeat imaging; extended antibiotics; surgical reassessment</td>
</tr>
<tr>
<td>ESR/CRP</td>
<td>At end of treatment; 3 months; PRN</td>
<td>Normalized or stable at new baseline</td>
<td>Elevated: repeat MRI; consider relapse</td>
</tr>
<tr>
<td>MRI spine</td>
<td>End of treatment; 3-6 months; PRN for symptoms</td>
<td>Resolved or stable; no new disease</td>
<td>New or worsening: relapse; restart antibiotics ± surgery</td>
</tr>
<tr>
<td>Functional assessment</td>
<td>Each visit</td>
<td>Improved or stable function</td>
<td>Rehabilitation referral; pain management; chronic deficit management</td>
</tr>
<tr>
<td>Spine stability / alignment</td>
<td>Radiographs at 6 weeks, 3 months, 6 months, 12 months if instability</td>
<td>Stable alignment; healing</td>
<td>Progressive kyphosis or instability: surgical stabilization</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<h3 id="admission-criteria">Admission Criteria<a class="headerlink" href="#admission-criteria" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Level of Care</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td>ICU admission</td>
<td>Sepsis/septic shock; hemodynamic instability; respiratory compromise; post-operative monitoring (surgeon-dependent); severe neurologic deficit with close monitoring needed</td>
</tr>
<tr>
<td>General medical/neurosurgery floor</td>
<td>ALL patients with confirmed or suspected SEA require admission; IV antibiotic initiation; neurologic monitoring; surgical evaluation; pre-operative preparation if surgery planned</td>
</tr>
<tr>
<td>Observation (NOT appropriate)</td>
<td>SEA is NEVER an observation diagnosis; all patients require admission until diagnosis confirmed/excluded and treatment initiated</td>
</tr>
</tbody>
</table>
<h3 id="discharge-criteria-transition-to-opat">Discharge Criteria (Transition to OPAT)<a class="headerlink" href="#discharge-criteria-transition-to-opat" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Criterion</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurologic stability</td>
<td>Stable or improving neurologic exam for ≥48-72h; no new deficits; if deficits present: stable plateau</td>
</tr>
<tr>
<td>Afebrile</td>
<td>Afebrile for ≥24-48h on antibiotics</td>
</tr>
<tr>
<td>Hemodynamically stable</td>
<td>Off vasopressors; stable vital signs</td>
</tr>
<tr>
<td>Organism identified</td>
<td>Blood cultures or surgical cultures positive with sensitivities back; targeted antibiotic regimen</td>
</tr>
<tr>
<td>Antibiotic regimen finalized</td>
<td>IV regimen established; OPAT-compatible dosing (once daily or BID preferred); duration plan documented</td>
</tr>
<tr>
<td>PICC line placed</td>
<td>Functional PICC; confirmed position; patient educated on care</td>
</tr>
<tr>
<td>Pain controlled</td>
<td>Adequate oral pain control; no IV opioid requirement</td>
</tr>
<tr>
<td>Safe home environment</td>
<td>Able to care for self or adequate caregiver support; refrigeration for medications; clean environment; phone access</td>
</tr>
<tr>
<td>Follow-up arranged</td>
<td>ID clinic within 1 week; spine surgery follow-up (1-2 weeks if post-op); PCP; VNA nursing visits 2-3x/week</td>
</tr>
<tr>
<td>Patient/family education</td>
<td>PICC care; infusion technique (if self-administering); signs of treatment failure (fever, worsening pain, new weakness); when to call/return</td>
</tr>
<tr>
<td>Pharmacy/infusion arranged</td>
<td>Home infusion company contracted; medications delivered; pump if needed</td>
</tr>
</tbody>
</table>
<h3 id="discharge-prescriptions-checklist">Discharge Prescriptions Checklist<a class="headerlink" href="#discharge-prescriptions-checklist" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr>
<td>IV antibiotic (specific to organism)</td>
<td>Dose, frequency, duration clearly documented (e.g., "Cefazolin 2g IV q8h x 6 weeks from [date]")</td>
</tr>
<tr>
<td>Oral analgesics</td>
<td>Acetaminophen, limited opioid PRN, gabapentin if neuropathic pain</td>
</tr>
<tr>
<td>DVT prophylaxis</td>
<td>Enoxaparin 40 mg SQ daily (if continuing) or transition to ambulation-based prevention</td>
</tr>
<tr>
<td>Rifampin (if applicable)</td>
<td>Only as adjunctive therapy; never monotherapy; document interactions</td>
</tr>
<tr>
<td>PPI / H2 blocker</td>
<td>If on steroids or at risk for GI bleed</td>
</tr>
<tr>
<td>Bowel regimen</td>
<td>If on opioids</td>
</tr>
<tr>
<td>Heparin flushes</td>
<td>For PICC maintenance</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<h3 id="key-guidelines">Key Guidelines<a class="headerlink" href="#key-guidelines" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Guideline</th>
<th>Source</th>
<th>Year</th>
<th>Key Recommendation</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vertebral Osteomyelitis Guidelines</td>
<td>IDSA Clinical Practice Guideline</td>
<td>2015</td>
<td>6-week IV antibiotic duration for vertebral osteomyelitis; MRI is imaging modality of choice; surgical drainage if neurologic deficit, spinal instability, or failure of medical therapy</td>
</tr>
<tr>
<td>Spinal Epidural Abscess Management</td>
<td>AANS/CNS Joint Guidelines</td>
<td>2017</td>
<td>Emergent surgical decompression recommended for patients with neurologic deficit; medical management may be considered for select patients without deficit and with identified organism</td>
</tr>
<tr>
<td>Native Vertebral Osteomyelitis</td>
<td>British Infection Association / British Orthopaedic Association</td>
<td>2015</td>
<td>MRI within 24h; blood cultures before antibiotics; echocardiogram for S. aureus bacteremia; 6-week IV antibiotics</td>
</tr>
</tbody>
</table>
<h3 id="landmark-studies">Landmark Studies<a class="headerlink" href="#landmark-studies" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Finding</th>
<th>Impact</th>
</tr>
</thead>
<tbody>
<tr>
<td>Darouiche (2006) — NEJM Review</td>
<td>Comprehensive review of SEA: S. aureus most common (60-70%); pre-operative neurologic status is #1 predictor of outcome; early surgery associated with better outcomes; medical management reasonable in selected cases without deficit</td>
<td>Established framework for surgical vs. medical management decision-making</td>
</tr>
<tr>
<td>Siddiq et al. (2004) — Meta-analysis</td>
<td>915 patients: Surgical treatment associated with better neurologic outcomes than medical management alone; patients presenting with neurologic deficit benefit most from early surgery</td>
<td>Supports surgical decompression as preferred approach, especially with neurologic deficit</td>
</tr>
<tr>
<td>Connor et al. (2013)</td>
<td>Timing of surgery: decompression within 24h of neurologic deficit associated with significantly better outcomes than delayed surgery</td>
<td>Established 24h window for surgical decompression</td>
</tr>
<tr>
<td>Patel et al. (2014)</td>
<td>Risk factors for poor outcome: advanced age, diabetes, MRSA, delayed diagnosis, pre-operative paralysis, cervical/thoracic location</td>
<td>Identified high-risk patients who may benefit from aggressive surgical approach</td>
</tr>
<tr>
<td>Berbari et al. (2015) — IDSA Guidelines</td>
<td>6-week IV antibiotic duration for vertebral osteomyelitis; longer for complicated cases (endocarditis, undrained abscess); rifampin adjunct for staphylococcal infections</td>
<td>Standardized antibiotic duration and adjunctive therapy</td>
</tr>
<tr>
<td>OVIVA Trial (2019)</td>
<td>Oral antibiotics non-inferior to IV for bone/joint infections after initial IV therapy in stable patients; oral switch after 2 weeks IV</td>
<td>Opened possibility of early oral transition for selected patients; reduces hospitalization/OPAT burden; requires careful patient selection</td>
</tr>
<tr>
<td>Reihsaus et al. (2000)</td>
<td>Meta-analysis: mortality 5%; permanent paralysis 4-22%; earlier surgery and better pre-operative function = better outcomes</td>
<td>Established prognostic importance of pre-operative neurologic status and early intervention</td>
</tr>
</tbody>
</table>
<h3 id="risk-factor-summary">Risk Factor Summary<a class="headerlink" href="#risk-factor-summary" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Major Risk Factors</th>
<th>Prevalence in SEA</th>
</tr>
</thead>
<tbody>
<tr>
<td>Diabetes mellitus</td>
<td>30-50%</td>
</tr>
<tr>
<td>Intravenous drug use (IVDU)</td>
<td>20-30%</td>
</tr>
<tr>
<td>Recent spinal procedure/injection</td>
<td>15-20%</td>
</tr>
<tr>
<td>Immunocompromised state (HIV, malignancy, steroids)</td>
<td>15-20%</td>
</tr>
<tr>
<td>Chronic renal failure/hemodialysis</td>
<td>10-15%</td>
</tr>
<tr>
<td>Alcoholism</td>
<td>10-15%</td>
</tr>
<tr>
<td>Distant infection source (UTI, endocarditis, skin)</td>
<td>30-40%</td>
</tr>
<tr>
<td>Recent bacteremia</td>
<td>20-30%</td>
</tr>
<tr>
<td>Spinal abnormality (prior surgery, degenerative disease)</td>
<td>15-20%</td>
</tr>
</tbody>
</table>
<h3 id="microbiology">Microbiology<a class="headerlink" href="#microbiology" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Organism</th>
<th>Frequency</th>
<th>Key Features</th>
</tr>
</thead>
<tbody>
<tr>
<td>Staphylococcus aureus</td>
<td>60-70% (MRSA 30-50% of S. aureus)</td>
<td>Most common; hematogenous spread; IVDU, skin infection, catheters; MRSA requires vancomycin</td>
</tr>
<tr>
<td>Coagulase-negative Staphylococci</td>
<td>5-10%</td>
<td>Post-procedural; hardware-associated</td>
</tr>
<tr>
<td>Streptococci (including viridans, pneumoniae)</td>
<td>5-10%</td>
<td>Endocarditis association; dental source</td>
</tr>
<tr>
<td>Gram-negative bacilli (E. coli, Pseudomonas, Klebsiella)</td>
<td>10-15%</td>
<td>Urinary source; IVDU (Pseudomonas); diabetics</td>
</tr>
<tr>
<td>Enterococcus</td>
<td>2-5%</td>
<td>Urinary source; GI/biliary source</td>
</tr>
<tr>
<td>Anaerobes</td>
<td>2-5%</td>
<td>Often polymicrobial; abdominal/pelvic source</td>
</tr>
<tr>
<td>Mycobacterium tuberculosis</td>
<td>&lt;5% (higher in endemic areas)</td>
<td>Subacute/chronic; Pott's disease; vertebral destruction; cold abscess; paraspinal extension</td>
</tr>
<tr>
<td>Fungi (Candida, Aspergillus)</td>
<td>&lt;2%</td>
<td>IVDU; immunocompromised; indwelling catheters</td>
</tr>
<tr>
<td>Culture-negative</td>
<td>10-20%</td>
<td>Prior antibiotics; fastidious organisms; consider TB, Brucella, fungi</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="appendices">APPENDICES<a class="headerlink" href="#appendices" title="Permanent link">&para;</a></h2>
<h3 id="appendix-a-surgical-vs-medical-management-algorithm">Appendix A: Surgical vs. Medical Management Algorithm<a class="headerlink" href="#appendix-a-surgical-vs-medical-management-algorithm" title="Permanent link">&para;</a></h3>
<div class="highlight"><pre><span></span><code>SPINAL EPIDURAL ABSCESS CONFIRMED ON MRI
                │
                ├── NEUROLOGIC DEFICIT PRESENT?
                │        (weakness, sensory level, bowel/bladder dysfunction)
                │
                │   YES → EMERGENT SURGICAL DECOMPRESSION + DRAINAGE
                │         (within 24h; within hours if rapidly progressive)
                │         + IV antibiotics
                │
                │   NO (neurologically intact) ↓
                │
                ├── OTHER SURGICAL INDICATIONS?
                │        • Sepsis/hemodynamic instability not improving
                │        • Significant spinal instability
                │        • Large abscess (&gt;2.5-3 cm)
                │        • Unknown organism (need tissue diagnosis)
                │        • Failure of medical therapy
                │
                │   YES → SURGICAL DRAINAGE + IV antibiotics
                │
                │   NO ↓
                │
                ├── CANDIDATE FOR MEDICAL MANAGEMENT?
                │        • No neurologic deficit
                │        • Organism identified (blood cultures positive)
                │        • Small abscess
                │        • Hemodynamically stable
                │        • Able to perform serial neuro exams (reliable)
                │
                │   YES → MEDICAL MANAGEMENT (IV antibiotics)
                │         WITH:
                │         • q2-4h neurologic checks (initially)
                │         • MRI at 48-72h (assess for enlargement)
                │         • Weekly MRI until improving
                │         • LOW threshold for surgery if ANY deterioration
                │
                │   NO → SURGICAL DRAINAGE + IV antibiotics
                │
                └── MEDICAL MANAGEMENT FAILURE?
                          • Neurologic deterioration (ANY)
                          • Persistent fever &gt;72h
                          • Enlarging abscess on imaging
                          • Persistent bacteremia
                          • Clinical worsening
                                    ↓
                          SURGICAL DRAINAGE (delayed surgery)
</code></pre></div>
<h3 id="appendix-b-antibiotic-selection-quick-reference">Appendix B: Antibiotic Selection Quick Reference<a class="headerlink" href="#appendix-b-antibiotic-selection-quick-reference" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Scenario</th>
<th>Empiric Regimen</th>
<th>Duration</th>
</tr>
</thead>
<tbody>
<tr>
<td>Standard empiric (unknown organism)</td>
<td>Vancomycin 15-20 mg/kg IV q8-12h + Ceftriaxone 2g IV q12h</td>
<td>Adjust to cultures → 6-8 weeks total</td>
</tr>
<tr>
<td>Penicillin/cephalosporin allergy</td>
<td>Vancomycin + Aztreonam 2g IV q8h OR Vancomycin + Fluoroquinolone</td>
<td>Adjust to cultures</td>
</tr>
<tr>
<td>Pseudomonas risk (IVDU, immunocompromised)</td>
<td>Vancomycin + Cefepime 2g IV q8h OR Vancomycin + Pip-tazo 4.5g IV q6h</td>
<td>Adjust to cultures</td>
</tr>
<tr>
<td><strong>MSSA (confirmed)</strong></td>
<td>Nafcillin 2g IV q4h OR Cefazolin 2g IV q8h ± Rifampin 300mg PO BID (if vertebral involvement)</td>
<td>6-8 weeks</td>
</tr>
<tr>
<td><strong>MRSA (confirmed)</strong></td>
<td>Vancomycin 15-20 mg/kg IV q8-12h (trough 15-20) ± Rifampin; ALT: Daptomycin 6-8 mg/kg IV daily (if no pneumonia)</td>
<td>6-8 weeks</td>
</tr>
<tr>
<td><strong>Streptococci</strong></td>
<td>Penicillin G 4 MU IV q4h OR Ceftriaxone 2g IV q12h</td>
<td>6 weeks</td>
</tr>
<tr>
<td><strong>Enterococcus (susceptible)</strong></td>
<td>Ampicillin 2g IV q4h ± Gentamicin 3mg/kg/day</td>
<td>6 weeks</td>
</tr>
<tr>
<td><strong>Gram-negative (susceptible)</strong></td>
<td>Ceftriaxone 2g IV q12h OR Ciprofloxacin 400mg IV q8h → PO 750mg BID</td>
<td>6 weeks</td>
</tr>
<tr>
<td><strong>With endocarditis</strong></td>
<td>Standard regimen for organism + extended duration (6 weeks minimum from first negative culture)</td>
<td>6+ weeks</td>
</tr>
</tbody>
</table>
<h3 id="appendix-c-esrcrp-monitoring-interpretation">Appendix C: ESR/CRP Monitoring Interpretation<a class="headerlink" href="#appendix-c-esrcrp-monitoring-interpretation" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Marker</th>
<th>Expected Trajectory</th>
<th>Concerning Trend</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRP</td>
<td>Peaks early; should begin declining within 1 week; normalize by 3-4 weeks</td>
<td>Rising or plateau after 1 week</td>
<td>Repeat imaging; reassess antibiotic coverage; consider surgery</td>
</tr>
<tr>
<td>ESR</td>
<td>May initially rise; begins declining at 2-3 weeks; may not normalize for 6-8 weeks or longer</td>
<td>Rising after 3-4 weeks; failure to decline after 4 weeks</td>
<td>Repeat imaging; ID reassessment; consider treatment failure</td>
</tr>
<tr>
<td>WBC</td>
<td>Should normalize within days-1 week</td>
<td>Persistent leukocytosis</td>
<td>Evaluate for secondary site; persistent infection</td>
</tr>
</tbody>
</table>
<p><strong>NOTE:</strong> ESR is slow to change and may remain elevated for weeks after successful treatment. CRP is more responsive and useful for early treatment monitoring. Imaging may appear worse at 2-4 weeks despite clinical improvement (this is normal — abscess organization and enhancement may increase before resolution).</p>
<h3 id="appendix-d-scoring-systems">Appendix D: Scoring Systems<a class="headerlink" href="#appendix-d-scoring-systems" title="Permanent link">&para;</a></h3>
<p><strong>Modified MESS Score (Medical vs. Surgical Management)</strong></p>
<p>Consider medical management if ALL of the following:
- [ ] No neurologic deficit
- [ ] Organism identified (blood cultures or biopsy positive)
- [ ] Abscess ≤2.5 cm in maximum dimension
- [ ] No significant spinal instability (SINS &lt;7)
- [ ] Hemodynamically stable (not septic shock)
- [ ] Patient can be monitored closely (serial exams possible)
- [ ] Patient is a poor surgical candidate (relative factor)</p>
<p>If ANY box is unchecked → strongly consider surgical drainage</p>
<p><strong>SINS (Spinal Instability Neoplastic Score) — Also useful for infection</strong></p>
<p>Can be applied to infectious destruction to assess instability (see MSCC template for full scoring details). SINS ≥7 suggests instability requiring surgical stabilization.</p>
<h3 id="appendix-e-post-discharge-opat-monitoring-checklist">Appendix E: Post-Discharge OPAT Monitoring Checklist<a class="headerlink" href="#appendix-e-post-discharge-opat-monitoring-checklist" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Monitoring</th>
<th>Frequency</th>
<th>Parameters</th>
</tr>
</thead>
<tbody>
<tr>
<td>ID clinic visit</td>
<td>Weekly</td>
<td>Clinical assessment, review labs, antibiotic tolerance, PICC site</td>
</tr>
<tr>
<td>CBC</td>
<td>Weekly</td>
<td>Anemia, thrombocytopenia (linezolid), leukopenia</td>
</tr>
<tr>
<td>CMP</td>
<td>Weekly</td>
<td>Renal function (vancomycin, aminoglycosides)</td>
</tr>
<tr>
<td>Vancomycin trough</td>
<td>Weekly (more frequent initially)</td>
<td>Target 15-20 mcg/mL</td>
</tr>
<tr>
<td>ESR, CRP</td>
<td>Weekly</td>
<td>Declining trend</td>
</tr>
<tr>
<td>LFTs</td>
<td>Weekly (if on rifampin or other hepatotoxic drugs)</td>
<td>Transaminases &lt;3x ULN</td>
</tr>
<tr>
<td>PICC site assessment</td>
<td>Each VNA visit (2-3x/week)</td>
<td>No erythema, drainage, tenderness</td>
</tr>
<tr>
<td>Neurologic exam</td>
<td>Each ID visit; patient self-monitoring daily</td>
<td>Stable; no new weakness/numbness</td>
</tr>
<tr>
<td>Temperature</td>
<td>Patient: daily</td>
<td>Afebrile</td>
</tr>
</tbody>
</table>
<hr />
<p><em>This template represents the initial build phase (Skill 1) and requires validation through the checker pipeline (Skills 2-6) before clinical deployment.</em></p>












                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>